Sally Choe, outgoing director of the FDA's Office of Generic Drugs

FDA's top gener­ic drug leader puts in her two weeks as GDU­FA III looms

The FDA is about to lose an­oth­er top leader with the de­par­ture of Sal­ly Choe, di­rec­tor of the FDA’s Of­fice of Gener­ic Drugs, on Oct …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.